STOCK TITAN

Sema4 to Participate at the 40th Annual J.P. Morgan Healthcare Conference in January

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Sema4 (Nasdaq: SMFR) announced that CEO Eric Schadt and CFO Isaac Ro will present at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 4:30 p.m. ET. The event will be held virtually, with a live and archived audio-only webcast accessible on Sema4's investor relations website. Sema4 is an AI-driven genomic and clinical data intelligence platform focused on advancing healthcare through data insights. The company aims to transform healthcare using AI and machine learning to optimize individualized health trajectories.

Positive
  • None.
Negative
  • None.

STAMFORD, Conn., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that Eric Schadt, PhD, Founder and Chief Executive Officer, and Isaac Ro, Chief Financial Officer, will participate at the upcoming 40th Annual J.P. Morgan Healthcare Conference, which is taking place virtually. Dr. Schadt and Mr. Ro will deliver a formal presentation on Monday, January 10th, 2022 at 4:30 p.m. ET. They will also be available for one-on-ones that same day.

A live and archived audio-only webcast of the presentation will be available on the “Events” section of the Sema4 investor relations website at https://ir.sema4.com/.

About Sema4

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

Investor Relations Contact:
Joel Kaufman
Sema4
investors@sema4.com

Media Contact:
Radley Moss
Sema4
radley.moss@sema4.com

 


FAQ

When will Sema4 present at the J.P. Morgan Healthcare Conference?

Sema4 will present on January 10, 2022, at 4:30 p.m. ET.

Where can I watch Sema4's presentation from the J.P. Morgan Conference?

The presentation will be available via a live and archived audio-only webcast on Sema4's investor relations website.

Who are the executives representing Sema4 at the conference?

Eric Schadt, CEO, and Isaac Ro, CFO, will represent Sema4.

What is Sema4's focus in healthcare?

Sema4 focuses on advancing healthcare through AI-driven genomic and clinical data intelligence.

What platform does Sema4 use for its health intelligence?

Sema4 uses the Centrellis® platform for data-driven insights in healthcare.

SMFR

:SMFR

SMFR Rankings

SMFR Latest News

SMFR Stock Data

120.14M